Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97790153 | 9779015 | 3 | F | 20160722 | 20131223 | 20160722 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-19927649 | BRISTOL MYERS SQUIBB | 76.00 | YR | M | Y | 0.00000 | 20160722 | CN | DE | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97790153 | 9779015 | 1 | PS | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Unknown | 500 MGX3/DAY | U | 20357 | 500 | MG | TID | ||||||
| 97790153 | 9779015 | 2 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | U | 0 | ||||||||||
| 97790153 | 9779015 | 3 | C | GLICLAZIDE | GLICLAZIDE | 1 | Unknown | 30 MG, QD | U | 0 | 30 | MG | QD | ||||||
| 97790153 | 9779015 | 4 | C | OLMESARTAN MEDOXOMIL. | OLMESARTAN MEDOXOMIL | 1 | Unknown | 1 DF= 20/12.5 MG | U | 0 | 1 | DF | QD | ||||||
| 97790153 | 9779015 | 5 | C | DELAPRIL HCL + INDAPAMIDE | 2 | Unknown | 30/2.5 | U | 0 | 2.5 | MG | QD | |||||||
| 97790153 | 9779015 | 6 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 1.25 MG, QD | U | 0 | 1.25 | MG | QD | ||||||
| 97790153 | 9779015 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97790153 | 9779015 | 1 | Type 2 diabetes mellitus |
| 97790153 | 9779015 | 2 | Product used for unknown indication |
| 97790153 | 9779015 | 3 | Product used for unknown indication |
| 97790153 | 9779015 | 4 | Product used for unknown indication |
| 97790153 | 9779015 | 5 | Product used for unknown indication |
| 97790153 | 9779015 | 6 | Product used for unknown indication |
| 97790153 | 9779015 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97790153 | 9779015 | HO |
| 97790153 | 9779015 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97790153 | 9779015 | Acute kidney injury | |
| 97790153 | 9779015 | Bacterial sepsis | |
| 97790153 | 9779015 | Blood creatinine increased | |
| 97790153 | 9779015 | Clostridium difficile colitis | |
| 97790153 | 9779015 | Disorientation | |
| 97790153 | 9779015 | Escherichia urinary tract infection | |
| 97790153 | 9779015 | Hyperlactacidaemia | |
| 97790153 | 9779015 | Hypoglycaemia | |
| 97790153 | 9779015 | Lethargy | |
| 97790153 | 9779015 | Metabolic acidosis | |
| 97790153 | 9779015 | Mitochondrial toxicity | |
| 97790153 | 9779015 | Toxicity to various agents | |
| 97790153 | 9779015 | Tubulointerstitial nephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |